News and Trends 5 Mar 2018
Danish Biotech Starts Phase III Atopic Dermatitis Trial With Failed Asthma Treatment
Danish biotech LEO Pharma started a Phase III trial in atopic dermatitis with an antibody that AstraZeneca dropped after failing two Phase III trials in asthma. LEO Pharma is taking…